Vimarsana
Biggest News Aggregation in the World

Page 4 - Presentation Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presentation Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presentation Date Today - Breaking & Trending Today

PathAI to Present Recent Advances in Applying AI-Powered Pathology Towards Liver Disease at the Amer - Vimarsana News

PathAI to Present Recent Advances in Applying AI-Powered Pathology Towards Liver Disease at the Amer

BOSTON--(BUSINESS WIRE)--#TLM22--PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, today announced that the organization’s recent research will be presented at the upcoming 2022 AASLD 2022 Liver Meeting*, which will be held in Washington, D.C. from November 4-8, 2022. At this...

LISCure Biosciences Announces Oral Presentation of New Drug Candidate for NASH at Upcoming AASLD The Liver Meeting 2022 - Vimarsana News

LISCure Biosciences Announces Oral Presentation of New Drug Candidate for NASH at Upcoming AASLD The Liver Meeting 2022

/PRNewswire/ -- LISCure Biosciences, a clinical-stage biopharmaceutical company developing microbe-oriented new drugs based on innovative technologies, today...

Genprex to Present at Upcoming June Investor Conferences - Vimarsana News

Genprex to Present at Upcoming June Investor Conferences

Corporate Presentation to Highlight Company's Gene Therapies for Cancer and DiabetesAUSTIN, Texas , June 2, 2022 /PRNewswire/ -- Genprex, Inc. ('G...

Genprex to Present at Upcoming Investor Conference in May 2022 - Vimarsana News

Genprex to Present at Upcoming Investor Conference in May 2022

/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...

Genprex to Participate in Upcoming Investor and Industry Conferences in April 2022 - Vimarsana News

Genprex to Participate in Upcoming Investor and Industry Conferences in April 2022

/PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies...